Indeed, on one hand, low levels of GPX3 have been detected in plasma and/or tissue samples from non-small-cell lung cancer (NSCLC), glioblastoma, hepatocellular carcinoma and colorectal carcinoma associated with a high rate of lipid peroxidation and poor patient outcome [228]. This evidence concerns the gene GPX3 and non-small cell lung carcinoma.